Kiener Peter A

CIK 00013281465 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001328146

Recent Transactions

48 trades

Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2026-01-02+24,400→ 24,400 total
Disposition to Issuer
LAVA Therapeutics NV
Share Options (Right to Buy)
2025-11-13−33,390→ 0 total
Award
LAVA Therapeutics NV
Common Shares (Right to Buy)
2025-02-13+33,390→ 33,390 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2025-01-02+24,400→ 24,400 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2024-01-02+24,400→ 24,400 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2023-06-21+40,000→ 40,000 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2023-03-23$2.86/sh+9,682→ 9,682 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2023-03-23$3.28/sh−9,325→ 357 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2023-03-23−9,682→ 96,062 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2023-01-03+10,000→ 10,000 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2022-06-22+40,000→ 40,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2022-01-03+10,000→ 10,000 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2021-11-16$2.86/sh+1,361→ 1,361 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-11-16−1,361→ 105,744 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2021-11-16$18.02/sh−1,361→ 0 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2021-11-15$2.86/sh+18,815→ 18,815 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-11-15−18,815→ 107,105 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2021-11-15$17.92/sh−18,815→ 0 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2021-06-25+40,000→ 40,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-01-04+10,000→ 10,000 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Options (Right to buy)
2020-06-23+40,000→ 40,000 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2020-01-25+20,000→ 20,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-01-02+8,000→ 8,000 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2019-01-25+20,000→ 20,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2019-01-02+8,000→ 8,000 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2018-10-24+30,000→ 30,000 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2018-06-12+9,600→ 9,600 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$9.67/sh−250,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$4.20/sh−87,203→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$6.15/sh−133,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2018-02-13$18.00/sh−44,856→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$3.18/sh−38,500→ 0 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-12-31$9.10/sh+329→ 44,856 total
Tax Payment
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2017-12-28$17.98/sh−27,496→ 44,527 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2017-12-07−50,000→ 242,567 total
Sale
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2017-12-07$16.50/sh−50,000→ 2,023 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2017-12-07$8.33/sh+50,000→ 52,023 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-09-30$9.10/sh+330→ 2,023 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-06-30$8.93/sh+336→ 1,693 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-03-31$9.35/sh+321→ 1,357 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2017-03-06+133,000→ 626,270 total
Award
Sucampo Pharmaceuticals, Inc.
Common stock
2017-03-06+70,000→ 70,000 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-12-31$10.46/sh+287→ 1,036 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-09-30$9.38/sh+320→ 749 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-06-30$9.32/sh+300→ 429 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-03-31$9.29/sh+129→ 129 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-03-02+116,270→ 493,270 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-04+77,000→ 377,000 total

Companies

Recent Filings

Address

C/O CUE BIOPHARMA, INC. 40 GUEST STREET

BOSTON, MA, 02135

View on SEC.gov